ACR Backs Ultrasound Guidance for Trigger Point Care
ACR urges Medicare to cover ultrasound guidance for high‑risk trigger point injections to improve safety and accuracy.
Read moreThe American College of Radiology® (ACR®) submitted comments to the Centers for Medicare and Medicaid Services (CMS) Jan. 24, that support the agency’s ongoing efforts to streamline and improve utilization management policies. CMS proposals would affect prior authorization in the 2026 Medicare Advantage program. The agency said proposed changes would ensure services are provided equitably irrespective of the delivery method (e.g., using artificial intelligence to make determinations). One proposal would require prior authorization metrics to be reported by each item or service rather than aggregated data, building on policies CMS included in prior rules to increase transparency to providers and beneficiaries.
ACR recommended CMS consider the use of a qualified Clinical Decision Support Mechanism (CDSM) to adhere to the proposals. The use of physician-developed and evidence-based Appropriate Use Criteria (AUC) can ensure that prior authorization processes can help reduce administrative burden, as well as lead to potential savings of $700 million annually to the Medicare program by reducing unnecessary imaging orders.
CMS released a fact sheet with more information about its proposals.
If you have questions, contact Kimberly Greck, ACR Senior Economic Policy Analyst.
ACR Backs Ultrasound Guidance for Trigger Point Care
ACR urges Medicare to cover ultrasound guidance for high‑risk trigger point injections to improve safety and accuracy.
Read moreACR Supports Bill to Stabilize Medicare Physician Pay
ACR backs bipartisan H.R. 8163 which will stabilize Medicare physician pay by easing budget neutrality, fixing data errors, and capping annual cuts.
Read moreACR Flags Concern With White House FY 2027 Budget Request
ACR raises concerns about Trump’s FY2027 budget, which cuts NIH by $6B, caps indirect costs, restructures institutes, and reduces ARPA‑H funding.
Read more